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Abstract
Background: Laboratory-induced dyspnea (breathing discomfort) in healthy subjects is widely used to study
perceptual mechanisms, yet the relationship between laboratory-induced dyspnea in healthy volunteers and
spontaneous dyspnea in patients with chronic lung disease is not well established. We compared affective
responses to dyspnea 1) in COPD patients vs. healthy volunteers (HV) undergoing the same laboratory stimulus;
2) in COPD during laboratory dyspnea vs. during activities of daily living (ADL).
Methods: We induced moderate and high dyspnea levels in 13 COPD patients and 12 HV by increasing end-tidal
CO2 (PETCO2) during restricted ventilation, evoking air hunger. We used the multidimensional dyspnea profile (MDP)
to measure intensity of sensory qualities (e.g., air hunger (AH) and work/effort (W/E)) as well as immediate
discomfort (A1) and secondary emotions (A2). Ten of the COPD subjects also completed the MDP outside the
laboratory following dyspnea evoked by ADL.
Results: COPD patients and HV reported similar levels of immediate discomfort relative to sensory intensity. COPD
patients and HV reported anxiety and frustration during laboratory-induced dyspnea; variation among individuals far
outweighed the small differences between subject groups. COPD patients reported similar intensities of sensory
qualities, discomfort, and emotions during ADL vs. during moderate laboratory dyspnea. Patients with COPD
described limiting ADL to avoid greater dyspnea.
Conclusions: In this pilot study, we found no evidence that a history of COPD alters the affective response to
laboratory-induced dyspnea, and no difference in affective response between dyspnea evoked by this laboratory
model and dyspnea evoked by ADL.
Keywords: Dyspnea, Symptom assessment, COPD
Background
How well do laboratory models contribute to our under-
standing of clinical dyspnea? Dyspnea is defined by the
American Thoracic Society as “… a subjective experience of
breathing discomfort that consists of qualitatively distinct
sensations that vary in intensity. The experience … may
induce secondary physiological and behavioral responses”
[1]. This shares features with definitions of pain, which has
been described as “an unpleasant sensory and emotional
experience associated with actual or potential tissue da-
mage, or described in terms of such damage” [2]. In the de-
velopment of pain theory the affective dimension of pain
has been divided into an initial stage (A1) of ‘immediate
unpleasantness or discomfort’ and a later stage of emotional
outcomes (A2) that may lead to behavioral outcomes [3-6].
The affective response to either pain or dyspnea can vary
independently of sensory intensity [7,8] Thus, both dyspnea
and pain are understood to have sensory and affective
dimensions and, in pain theory, it is accepted that labora-
tory models have contributed to a better understanding
of neurophysiological mechanisms and treatment [9].
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sion of the multidimensional characteristics of pain
and dyspnea.)
As is the case with pain models, a multidimensional
perspective on dyspnea may also be useful for addressing
question about the transferability of laboratory models
to practice. A customary single-dimension measure of
dyspnea, such as use of a modified Borg scale to rate sen-
sory intensity (SI), may not adequately assess the differences
seen between clinical and laboratory dyspnea. Although SI
may predict affective response, the relationships among SI,
A1 and A2 are likely to be influenced by factors such as
sensory quality (SQ), pathophysiology, and environment.
Thus, while laboratory models have been valuable in defin-
ing neural mechanisms of dyspnea, and in testing potential
palliative interventions, they are prone to the criticism that
clinical dyspnea is fundamentally different than laboratory
dyspnea and that the experience of patients greatly alters
their perceptual and emotional responses [11-14]. For
example, laboratory interventions probably stimulate
only a subset of the sensory receptors activated by
pathophysiological processes and may give rise to dif-
ferent qualities of sensation. There are differences between
the psychological environment of the laboratory and daily
life: knowing that experimental risks are minimal, and that
one can stop an experiment at any time, might reduce fear
and anxiety compared to dyspnea associated with disease
conditions that cannot be controlled.
In this study, we tested the extent to which one
laboratory model of dyspnea (air hunger) evokes
different affective responses between COPD patients
and HV. We also assessed differences in affective res-
ponses of COPD patients to the lab dyspnea model
and dyspnea associated with activities of daily living
(ADL). Using a multidimensional measurement instru-
ment that incorporates qualitative and affective mea-
surements, we first compared dyspnea perceptions of
Healthy and COPD volunteers in the laboratory [15].
We, then compared dyspnea perception in the labora-
tory with dyspnea perception in the daily lives of the
same COPD volunteers. We tested three statistical
null hypotheses:
H0_1 During experimentally induced dyspnea, the
relationship between immediate affective
response (unpleasantness, discomfort or A1)
and the intensity of specific sensory qualities
(SI) does not differ between healthy and
COPD volunteers.
H0_2 During experimentally induced dyspnea, the
relationship between immediate unpleasantness,
discomfort and emotional affective response
(A2 ) does not differ between healthy and
COPD volunteers.
H0_3 In individuals with COPD, the relationship
between immediate unpleasantness, discomfort
and emotional affective response does not differ
between dyspnea associated with activities of daily
living (ADL) and experimentally induced dyspnea.
Methods
Subjects
Subjects at least 45 years old were recruited through
advertisement and referral by pulmonary physicians. We
screened subjects for self-reported cardiopulmonary or
neurological conditions, and administered the Baseline
Symptom Inventory (BSI-18) to identify subjects prone to
panic disorder [16]. No subjects were excluded based
on BSI results. In order to assure comparable baseline
(pre-stimulus) measurement conditions between COPD
and healthy volunteers, we selected COPD participants
who reported dyspnea during exercise but not at rest.
COPD diagnosis was confirmed by pulmonary function
tests (PFTs) and compatible history and symptoms [17,18].
Healthy volunteers reported no history of physician-
confirmed COPD, no use of respiratory medication, and no
exercise limitation due to respiratory symptoms. Prior to
each experimental day, subjects were asked about acute
changes in health status such as respiratory infections,
COPD exacerbation, and change in medication type or
dose. The study protocol was approved by the Committee
on Clinical Investigation of the Beth Israel Deaconess
Medical Center, where all experiments were performed
(Protocol # 2006P000468). All subjects gave written
informed consent.
Physiologic measurements
Subjects began each session by sitting comfortably and
reading a standard text while end-tidal PCO2 (PETCO2)
was sampled in one nostril through an unobtrusive tube.
During experiments, subjects breathed through a mouth-
piece; tidal PCO2 and pressure at the airway opening were
sampled in the common line, and we monitored pulse rate,
arterial oxygen saturation and blood pressure throughout
the experiment. Data were digitized and recorded for
later analysis (PowerLab 16/30, AD Instruments, Colorado
Springs, CO).
Stimulus and protocol
Using a standardized script (see Additional file 1, text of
standardized script), we instructed subjects on the details
of the experimental protocol. On separate practice days,
we familiarized subjects with the dyspnea experience to
stabilize the relationship between stimulus and rating and
to identify subjects who were unable to provide ratings
reliably related to stimulus level [19]. Five unreliable raters
(2 HV, 3 COPD) were excluded. These excluded subjects
all had R
2 value <0.49 (R < 0.7) for the regression of
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PETCO2.
We employed a hypercapnic stimulus with minute
ventilation constrained to 0.13 liters/min/kg (termed here
'standard ventilation', a level modestly greater than normal
resting ventilation), by limiting flow to an inspiratory
reservoir bag (see figure in Additional file 2 schematic
of hypercapnic stimulus apparatus and on-line rating
device). To control frequency and tidal volume, subjects
breathed at 14 to 16 breaths per minute in time with an
audible signal. The standard ventilation was achieved by
all subjects with no evidence of dynamic hyperinflation.
Stimulus strength, i.e., change in PETCO2 above resting
value, was varied 3 to 5 times in an arbitrary pattern to
minimize subject expectation [20]. At each step, the goal
was to achieve a constant PETCO2 for 2 minutes. We used
continuous on-line ratings to target experimental end-
points of moderate and high levels of breathing discomfort
(A1) (60% and 90% full scale [FS]).
Each test lasted approximately 15 minutes, and subjects
completed a minimum of one test concluding at each of
the two targeted end-points (moderate and high discom-
fort) The Multidimensional Dyspnea Profile (MDP) was
completed immediately after each test, and subjects were
instructed to focus on the final 30 to 60 seconds of the
stimulus exposure (corresponding to the targeted end-
point). Physiologic data associated with MDP ratings were
averaged over the same 30 to 60 seconds.
Measurement of dyspnea
During laboratory dyspnea challenge, subjects continuously
rated ‘breathing discomfort (BD), or unpleasantness’ using
an online ‘Visual Analog Scale’ (BDVAS) anchored with
“No Discomfort” at 0 and “Stop Now” at 100% of full scale
(%FS).
aThe experimenters immediately reduced the stimu-
lus if the subject rated 100%. The BDVAS was intended as
a continuous measure of A1 (immediate discomfort), and
was used to target comparable levels of A1 among subjects
prior to completion of the MDP (see Additional file 2).
Following each laboratory dyspnea challenge, and fol-
lowing periods of activity at home, subjects reported
respiratory sensations and resulting emotional responses
using the Multidimensional Dyspnea Profile (MDP)
[8,15]. Respondents rated items on 10 point visual ana-
log scales (VAS) related to: perceived overall sensory in-
tensity (SI); immediate unpleasantness of the dyspnea
experience (immediate affective response or A1); the
intensity of specific sensory qualities (SQ) such as a sense
of “air hunger” and “breathing work and effort” [21-23]
and emotional responses such as fear, anxiety and frustra-
tion (secondary affective response, A2). Respondents also
chose a single SQ that most aptly described the dyspnea
sensation. (See Additional file 3 for a schematic represen-
tation of the MDP) The MDP, which can be completed in
2–4 minutes, is designed for both laboratory and clinical
use, and can be administered immediately following an
event or used for later recall. The construct validity,
responsiveness and reliability of this instrument have
been described [15].
Protocol for dyspnea assessment during activities of daily
living
After completing all laboratory experiments, COPD
patients took home copies of the MDP to complete
daily for 2 weeks following episodes of dyspnea associated
with normal Activities of Daily Living (ADL). Patients also
recorded the events that had provoked the reported
dyspnea. MDP responses were averaged within subject
to provide equal weighting, and were then compared
to responses obtained from the same subjects following
laboratory dyspnea.
Statistical analyses
Descriptive statistics by subject type and stimulus inten-
sity are reported as means and standard deviations. The
statistical significance of between group (Healthy vs.
COPD) item response differences was evaluated by the
Mann–Whitney U test, while the Wilcoxon test was
used to evaluate within group (by stimulus intensity) dif-
ferences. Repeated measures ANOVA was used to assess
group by stimulus intensity interactions. Additional ana-
lyses to assess internal consistency and test-retest reli-
ability of the MDP in a laboratory setting are provided
in Additional file 4 (MDP test-retest measures). Statis-
tical analyses were performed using SPSS version 12.0.1.
Results
Subjects
Analyses were performed on 12 HV and 13 COPD
patients whose characteristics are shown in Table 1.
(See Additional file 5 for detailed subject data) We
assessed the effect of stimulus strength using data
from 11 HV and 12 COPD patients, for whom MDP
responses were available at both moderate and high
unpleasantness ratings. We assessed test-retest reliability
of the MDP in nineteen subjects (12 COPD, 7 Healthy)
who gave BDVAS ratings during the final minute of the
laboratory stimulus on separate days that matched within
10% full scale (Additional file 4). Home MDP data were
collected from 10 of the COPD patients who had been
tested in the laboratory.
Laboratory challenge: COPD patients vs. HV
As would be expected from the similarity in underlying
constructs, on-line BDVAS corresponded closely to
subsequent MDP ratings of A1 (mean difference 2.5%
FS; R
2 =0.704). There was no significant difference by
s u b j e c tt y p e( p = 0 . 8 0b yt w ow a yA N O V Ao fs u b j e c t
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plot of A1 vs. BDVAS by subject type).
The stimulus levels (increase in PETCO2 above resting)
that evoked moderate (healthy 5.5±3.7, COPD 2.8 ±3.8)
and high (healthy 10.5 ±4.5, COPD 6.4± 7.5) ratings
were not significantly different between subject groups
(P =0.18), and mean BDVAS and A1 were equivalent at
both stimulus levels (Figure 1).
Choice of sensory quality descriptors: COPD patients
vs. HV
The set of descriptor phrases “I am not getting enough
air, I feel hunger for air, or I am smothering” was chosen
as the best descriptor by 52% of subjects following mo-
derate, and 65% of subjects following high laboratory
stimulus presentations. We term this descriptor group
air hunger (AH). The descriptor phrase “I feel that my
breathing requires work or effort” ( W E )w a sc h o s e na st h e
best descriptor by 35% of subjects following moderate and
22% of subjects following high laboratory stimulus presen-
tations. All other descriptor phrases, such as “my chest or
lungs feel tight”,o r“I am breathing a lot” were chosen as
best descriptor by only 13% of subjects following laboratory
stimulus presentations. Best descriptor choice did not differ
significantly between COPD and healthy subjects.
Despite discrimination of best descriptor choice at
both stimulus levels, subjects provided roughly equal
scale ratings of both sensory qualities; this apparent
contradiction is discussed below. Following stimulus
exposure at the moderate level, subjects rated AH at
46% full scale compared with 57% for WE (p =0.035).
Following exposure at the high level, corresponding ratings
were 83% versus 86% (p=0.223). Sensory quality ratings
did not differ significantly by subject type.
Unpleasantness and global sensory intensity responses:
COPD patients vs. HV
A1 differed significantly between levels of perceived sen-
sory intensity, (p<0.001). We compared A1 ratings bet-
ween groups at roughly matched levels of air hunger.
There were no significant differences in mean ratings of
A1 between healthy and COPD patients (by repeated
measures ANOVA, p =0.448). To account for small
differences in sensory intensity within level, we plotted
mean A1 versus mean ratings of AH by stimulus level
and subject type (Figure 2).
Emotional response to laboratory dyspnea: COPD
patients vs. HV
Both HV and COPD patients rated appreciable levels of
“anxiety” and “frustration” related to laboratory exposure
to the dyspnea challenge (Table 2). These emotions in-
creased significantly at higher stimulus intensity (by re-
peated measures ANOVA, p< .001 for anxiety and p=.003
for frustration). However, there was no significant dif-
ference in emotional response between HV and COPD
patients (Figure 3). For difference in rating by subject type
(controlling for stimulus level), p = .321 and .952 for anxiety
Figure 1 Plot of BDVAS and A1 ratings during limited volume
ventilation as a function of change in stimulus intensity
(ΔPETCO2). The BDVAS was used to continuously rate breathing
discomfort throughout a trial lasting 10 to 15 min; the value shown
in this graph is the mean BDVAS over the final 30 seconds of the
trial. BDVAS scale ranged from zero to ‘stop now’, which indicated
that the subject had reached his or her limit of tolerance. A1 was
assessed immediately following the trial, and the subject was asked
to focus on the last 30 seconds of the trial when responding. The A1
scale of unpleasantness ranged from ‘neutral’ to ‘unbearable’.
Table 1 Subject characteristics
N male (%) Age* Height
(cm)
Weight
(kg)
BMI
(kg/m
2)
BSI-18 Resting PETCO2
(mmHg)
GOLD
stages
FEV1/FVC FEV1,
(%Pred)
COPD 7 (54%) 67.5 171.8 80.8 27.5 6.2 37.8 III 5 58.4 46.9
N= 13 (7.8
#) (8.8) (22.1) (7.9) (6.1) (1.8) II 6 (22.1) (15.8)
(56–86
&)I 2
Healthy 8 (67%) 54.8 (4.8) 172.2 77.3 25.9 2.1 40.0
N= 12 (46–61) (10.8) (13.8) (2.8) (3.6) (2.8)
*P< 0.001 by Mann–Whitney U for difference between healthy and COPD subjects.
#(SD).
&(range).
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rated anger and depression less than 10% FS following
stimulus exposure.
Laboratory dyspnea vs. dyspnea of daily living
(subset of 10 pts)
Ten COPD patients completed take-home dyspnea
instruments. An average of 14 MDPs were completed by
each subject following a separate instance of dyspnea
over the course of two to three weeks. Fifty-one percent
of 140 subject reports indicated that dyspnea episodes
occurred while walking or climbing stairs, often when
carrying groceries, laundry etc. Forty-eight percent of
reports indicated that subjects curtailed the intensity or
duration of ADL in order to limit dyspnea. Unfortunately
the layout of the self-completed MDP used in this study
failed to focus the subject’s attention on the requirement
to choose the best descriptor, thus best-descriptor data
were insufficient for analysis.
Relationship of A1 to sensory intensity during ADL in
COPD patients
The relationship between A1 and perceived air hunger
was remarkably similar between ADL and the laboratory.
Serendipitously, average A1 ratings associated with ADL
were close to those earlier reported by the same subjects
following the arbitrarily targeted moderate level of labora-
tory stimulus (Figure 4). This allows comparison of the
other dimensions of dyspnea with reasonable confidence
that non-linearity is not an issue.
The ratings of SQ during ADL were not significantly
different than ratings obtained during the moderate level
laboratory stimulus.
Emotional response during ADL in COPD patients
The anxiety or frustration associated with respiratory
discomfort was nearly the same whether the dyspnea
was experienced during ADL at home or during moderate
level laboratory stimulus (Figure 5). Subjects rated both
anxiety (5a) and frustration (5b) at approximately 20%
FS, about the same as during the moderate laboratory
stimulus (p>0.5).
Discussion
Summary conclusions
These are the first observations comparing multiple
aspects of the dyspnea experience of HV and COPD
patients following exposure to a laboratory dyspnea
challenge that is physiologically equivalent in the two
groups. Exercise has different physiologic implications
for respiratory function in COPD, especially tidal vol-
ume limitation because of dynamic elevation of FRC
[24,25], resulting in different qualities of dyspnea sen-
sation and affective response [22]. Consequently, we
selected a stimulus that evoked dyspnea without in-
creased ventilation in an attempt to provoke the same
sensation in both groups.
Our results are consistent with the three null hypotheses
proposed: 1) COPD patients and HV report similar un-
pleasantness for a given intensity of sensation (AH and
WE) in laboratory experiments; 2) COPD patients and HV
reported similar emotional responses during laboratory
dyspnea; 3) COPD patients reported similar frustration
and anxiety with ADL as they did with laboratory dyspnea.
Given the modest sample size, we consider below
whether any important differences are likely to have gone
undetected by this study (‘Type II error’).
Do patients with chronic lung disease have a different
affective response to dyspnea?
We showed that COPD patients and HV undergoing the
same laboratory dyspnea experience report the same qual-
ity of sensation and the same immediate unpleasantness.
This implies that long experience to clinical dyspnea has
Figure 2 Plot of ‘unpleasantness’ (A1) as a function of air
hunger intensity for two groups of subjects, COPD patients
(open circles, dashed line) and healthy controls (closed circles,
solid line). Both groups were exposed to moderate and high
stimuli. There was no difference between the groups. The A1 scale of
unpleasantness ranged from ‘neutral’ to ‘unbearable’;t h ea i rh u n g e r
scale ranged from zero (‘none’)t o‘as intense as I can imagine’.
Table 2 A2 responses of healthy volunteers and COPD
patients to moderate and high laboratory stimuli
Stimulus level Subject type Anxious Frustrated Afraid
Moderate Healthy 20.0* (5.8) 14.2 (6.0) 5.9 (3.2)
COPD 27.6 (6.3) 19.7 (5.2) 12.8 (5.1)
High Healthy 40.5 (11.0) 39.0 (8.6) 18.6 (7.7)
COPD 54.2 (9.4) 33.3 (8.7) 30.4 (10.0)
Ratings are given as % full scale ± se.
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discomfort. This is consistent with findings in competitive
breath-hold divers whose perception of laboratory air
hunger is not different from normal subjects [26].
We observed that the emotional component of dys-
pnea differed widely among individuals at both moderate
and high strength laboratory stimulus levels (see graph
in Additional file 7, interindividual variability of anxiety
ratings (A2) following moderate and high level stimulus
exposure). This type of individual difference in the
emotional response to unpleasant stimuli has been termed
affective style, and is likely an individual characteristic [27].
This affective style, captured by the MDP, may contribute
to differences in clinical expression of symptoms and,
ultimately, influence whether a particular individual seeks
medical care for her symptom [15].
In COPD patients, does the affective response to
laboratory dyspnea challenge differ from the affective
response to dyspnea in daily life?
COPD patients reported episodes of dyspnea during
ADL that were similar in intensity and unpleasantness
to our moderate strength laboratory dyspnea challenge.
Ratings of anxiety, frustration and fear were in the lower
third of the scale. Patients frequently reported that they
limit physical activity in daily life to avoid high dyspnea
levels, probably to avoid discomfort and adverse emo-
tions. The relatively low A2 ratings may reflect a sense
of control during daily activity. At higher levels of la-
boratory stimulus, ratings often exceeded 50%FS, but,
probably because subjects were also in control of the
maximal stimulus, anxiety ratings seldom reached 100%.
This contrasts with emotional responses to dyspnea in
acutely ill patients with inescapable dyspnea. For ex-
ample, as noted by one patient after rating A1 at 75%
FS and anxiety at 50%FS, “if I was alone and breath-
ing like this I would be scared, would definitely feel
m o r ea f r a i d[ a th o m e ]n o tk n o w i n gh o wl o n gi tw i l l
last”. This is consistent with reports from patients seeking
treatment in an emergency room [13].
Limitations of this study
Sample size
We studied a relatively small number of subjects, thus
the lack of statistically significant differences may reflect
Type II errors. What is the likelihood that Type II errors
could have obscured functionally important differences?
Figure 3 Plot of anxiety rating (panel 3a) and frustration rating (panel 3b) vs. unpleasantness (A1) for healthy subjects (closed circles,
solid line) and COPD patients (open circles, dashed line). Ratings are for the last 30 seconds of moderate intensity and high intensity
laboratory stimuli. Scale maxima were defined as ‘Unbearable’ for unpleasantness and ‘most I can imagine’ for emotion. Error bars reflect standard errors.
Figure 4 Plot of Unpleasantness (A1) as a function of air
hunger rating for the 10 COPD subjects who completed daily
questionnaires at home. Open circles connected by line represent
dyspnea during moderate and high PETCO2 during restricted ventilation
in the laboratory; closed circle represents dyspnea experienced during
activities of daily living, such as walking or climbing stairs. Scale maxima
were defined as ‘Unbearable’ for unpleasantness and ‘as intense as I can
imagine’ for air hunger. Error bars reflect standard errors.
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ponses by subject type (healthy vs. COPD) is virtually nil
at moderate stimulus, and at most 14% FS at high sti-
mulus for anxious (see Figure 3). Based on current data
our best estimate is that anxiety in COPD patients du-
ring laboratory stimuli is very similar to healthy controls.
However, because variance was large (coefficient of vari-
ation >60% for both HV and COPD patients), we can
not state with confidence that anxiety in COPD is less
than 20% FS different from controls following exposure
to high intensity laboratory stimulus. Even this worst-case
estimate would not be large enough to invalidate the use
of the air hunger laboratory model for investigation of
dyspnea. As described above, the large SD was mainly
attributable to inter-, rather than intra-, individual vari-
ation of emotional responses in both subject groups. Re-
peat assessment in the laboratory (see Additional file 4)
and clinical [15] setting demonstrate intraindividual con-
sistency of affective ratings using the MDP. Thus, the ef-
fect of individual psychological characteristics seems to
overwhelm the effect of chronic respiratory disease on the
emotional response to dyspnea.
Sample characteristics
COPD patients (67.5±7.8) were older than healthy volun-
teers (54.8±4.8). We found no reports of age associated
differences in dyspnea perception during well-controlled
stimulus exposure among adult subjects who differ in age
by 10 to 15 years. Indirect evidence of age associated
differences comes from studies of resistive load thres-
hold detection among older asthmatics [28,29]. As we
selected a stimulus not directly affected by mechanical
load, we don’t think this evidence is relevant to interpret-
ation of our results. To affirm this conclusion, we selected
the 6 (50%) healthy volunteers (ages 56–61) and 8 (66%)
COPD patients (ages 56–67) with overlapping age ranges.
As in the larger groups, results for this subset were similar
between subject types.
Ability of MDP to discriminate sensory quality
There was a clear favorite choice of descriptor that best
characterized the sensation during laboratory dyspnea,
yet there was considerable overlap in the ratings of descrip-
tors on a scale from 0–10. Our interpretation of this is that
when subjects are presented with several parallel rating
scales, many tend not to greatly separate ratings. On the
other hand, when forced to make a choice about the most
prominent sensation, the subject makes a judgment. As
expected from results in earlier studies that exposed
subjects to a similar dyspnea stimulus [8], air hunger
was the best descriptor. In addition, high ratings of
‘work effort’ may reflect a combination of respiratory
muscle effort and mental effort. Subjects presented
with the supplementary descriptor “my breathing required
concentration or mental effort” rated this item 62%FS and
rated muscle work 56%FS.
PETCO2 measurement
The average changes from resting (ΔPETCO2) associated
with the BDVAS ratings differed somewhat between
COPD patients and HV, although the difference was
not statistically significant. In COPD, PETCO2 is not a
reliable indicator of arterial blood gasses due to heteroge-
neous ventilation/perfusion ratio, the effect of which
causes PETCO2-PaCO2 difference to vary with tidal
Figure 5 Plot of anxiety (5a) and frustration (5b) ratings as a
function of unpleasantness rating in COPD subjects during
dyspnea caused by activities of daily living (ADL) and by a
laboratory stimulus evoking air hunger. Open circles connected
by line represent dyspnea during moderate and high PETCO2 during
restricted ventilation in the laboratory; closed circle represents
dyspnea experienced during activities of daily living, such as walking
or climbing stairs. Scale maxima were defined as ‘Unbearable’ for
unpleasantness and ‘most I can imagine’ for emotion. Error bars
reflect standard errors.
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ratings of SI for a given ΔPCO2 is known to vary widely
among individuals [30]. For these reasons we chose to
match stimulus strength based on on-line ratings, not
on ΔPCO2. Because the range of ΔPCO2 was modest,
approximately 2–10 mmHg, symptoms and signs attri-
butable to elevated PaCO2, such as headache, elevated
blood pressure and flushing, did not appear to affect dis-
comfort ratings.
Conclusions and implications
Our laboratory dyspnea model can produce sensory and
affective responses in both HV and COPD patients similar
to those experienced by COPD patients during exertion.
Furthermore, similar sensory and affective responses are
evoked in both healthy subjects and those with chronic dis-
ease. The laboratory intervention is capable of producing
much stronger responses than moderately impaired COPD
patients ordinarily allow themselves to experience during
ADL, thus the laboratory intervention can be adjusted to
match a wide range of clinical severity. We conclude that,
despite very real differences between laboratory and clinical
settings, laboratory results obtained by studying healthy in-
dividuals can be useful in examining mechanisms and test-
ing treatments for patients with lung disease.
Our results carry implications for future dyspnea
research. First, much dyspnea research is conducted on
healthy individuals in laboratory settings; these data sug-
gest that if the laboratory model is well chosen, such stud-
ies have relevance for our understanding of breathlessness
associated with disease. Second, assessment of dyspnea
has usually been limited to measurement within a single
dimension such as intensity of a given, often non-specific,
sensation. Our data argue that instruments such as the
MDP can provide insight into affective as well as sensory
experiences of dyspnea. The overall symptom burden of
and functional limitation associated with clinical dyspnea
may be heavily influenced by affective responses, and
effective treatment of dyspnea, particularly in chronic
disease, may depend upon manipulation of its affective
components. Thus, the multidimensional assessment of
both laboratory-evoked and naturally occurring dyspnea is
an approach that can provide guidance for translating
bench results to bedside application.
Endnotes
a Throughout the article the terms ‘unpleasantness’ and
‘discomfort’ are considered equivalent. While ‘Unpleasant-
ness’ is more commonly used to describe the immediate
affective response (A1) in multi multidimensional mo-
dels of pain, ‘Discomfort’ is employed in the ATS
dyspnea statement.
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